Stryker Corp (SYK)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$366.45

Buy

$368.01

arrow-down$-2.31 (-0.63%)

Prices updated at 28 Dec 2024, 00:32 EST

Prices minimum 15 mins delay

Prices in USD

Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.

S&P 500

-1.11%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2022	2023
	18,449m	20,498m
	11,578m	13,058m
	3,042m	3,906m
	16.49	19.06
	2,358m	3,165m
	4,040m	4,934m
Sales, General and administrative	6,455m	7,129m
Interest expenses	-	-
Provision for income taxes	325m	508m
Operating expenses	8,536m	9,152m
Income before taxes	2,683m	3,673m
Net income available to common shareholders	2,358m	3,165m
	6.23	8.34
Net interest income	-	-
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	6.17	8.25
Free cash flow per share	5.2718	6.6993
Book value/share	43.4724	47.106
Debt equity ratio	0.713589	0.586296

Balance sheet

Year chevron-l-regular chevron-r-regular	2022	2023
Current assets	10,275m	12,518m
Current liabilities	6,303m	7,921m
Total capital	28,473m	29,494m
Total debt	13,048m	12,995m
Total equity	16,616m	18,593m
Total non current liabilities	-	-
Loans	11,857m	10,901m
Total assets	36,884m	39,912m
Total liabilities	-	-
Cash and cash equivalents	1,844m	2,971m
Common stock	379m	380m

Cash flow

Year chevron-l-regular chevron-r-regular	2022	2023
Cash at beginning of period	2,944m	1,844m
Cash dividends paid	-1,051m	-1,139m
	2,036m	3,136m
Investments (gains) losses	-2,924m	-962m
	1,844m	2,971m
Net income	-	-
	2,624m	3,711m
	-588m	-575m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.